ExodusPoint Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

ExodusPoint Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-39,453	Closed	-$795K	–	2798
2021 Q3	$795K	Buy	+39,453	New	+$1.09M	0.01%	1134
2021 Q1	–	Sell	-97,257	Closed	-$2.14M	–	2788
2020 Q4	$2.14M	Sell	97,257 -7,078	-7%	-$156K	0.02%	516
2020 Q3	$1.88M	Buy	+104,335	New	+$2.16M	0.04%	427
2020 Q1	–	Sell	-9,484	Closed	-$209K	–	1835
2019 Q4	$209K	Buy	+9,484	New	+$191K	﹤0.01%	1325

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

ExodusPoint Capital Management's DRNA Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 39,453 shares — an estimated $795K sold.

ExodusPoint Capital Management first reported a position in DRNA in Q4 2019 and held it in 4 quarters. The position peaked at $2.14M in Q4 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

ExodusPoint Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 39,453 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $795K.
ExodusPoint Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
ExodusPoint Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $2.14M in Q4 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.